ERIKA RUMBLE: Open Payments
NPI 1437695715 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,605 in 51 payments from 15 companies in 2025. Trend: 2023 $172 · 2024 $420 · 2025 $1,605
Food & beverage: $1,359Education: $246
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 11 | $499 |
| Lilly USA, LLC | 6 | $209 |
| Gilead Sciences, Inc. | 2 | $137 |
| Genentech, Inc. | 1 | $131 |
| Stemline Therapeutics Inc. | 6 | $114 |
| Merck Sharp & Dohme LLC | 5 | $106 |
| Eisai Inc. | 4 | $102 |
| AstraZeneca Pharmaceuticals LP | 4 | $82 |
| Novartis Pharmaceuticals Corporation | 4 | $77 |
| Genentech USA, Inc. | 2 | $43 |
Products named: Enhertu, Itovebi, DATROWAY, KEYTRUDA, Lenvima, Orserdu, KISQALI, VERZENIO.
Industry payments across OK — which companies pay providers there.
